Impact of the microenvironment on the pathogenesis of mucosa-associated lymphoid tissue lymphomas.

Activated immune cells Helicobacter pylori Microenvironment Mucosa-associated lymphoid tissue lymphoma Tumor microenvironment

Journal

World journal of gastrointestinal oncology
ISSN: 1948-5204
Titre abrégé: World J Gastrointest Oncol
Pays: China
ID NLM: 101532470

Informations de publication

Date de publication:
15 Jan 2022
Historique:
received: 25 02 2021
revised: 16 05 2021
accepted: 09 12 2021
entrez: 4 2 2022
pubmed: 5 2 2022
medline: 5 2 2022
Statut: ppublish

Résumé

Approximately 8% of all non-Hodgkin lymphomas are extranodal marginal zone B cell lymphomas of mucosa-associated lymphoid tissue (MALT), also known as MALT lymphomas. These arise at a wide range of different extranodal sites, with most cases affecting the stomach, the lung, the ocular adnexa and the thyroid. The small intestine is involved in a lower percentage of cases. Lymphoma growth in the early stages is associated with long-lasting chronic inflammation provoked by bacterial infections (

Identifiants

pubmed: 35116108
doi: 10.4251/wjgo.v14.i1.153
pmc: PMC8790412
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

153-162

Informations de copyright

©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict-of-interest statement: The authors declare no conflicts of interest for this article.

Références

J Clin Pathol. 1995 May;48(5):395-7
pubmed: 7629280
World J Gastroenterol. 2005 Dec 14;11(46):7384-5
pubmed: 16437648
J Biol Chem. 2001 Aug 17;276(33):30589-97
pubmed: 11387339
Inflammopharmacology. 2017 Aug;25(4):415-429
pubmed: 28516374
J Clin Med. 2020 Nov 24;9(12):
pubmed: 33255258
Ann Oncol. 2015 Aug;26(8):1760-5
pubmed: 25935794
Am J Clin Pathol. 2011 Jan;135(1):70-5
pubmed: 21173126
Br J Haematol. 2012 Sep;158(5):662-4
pubmed: 22640364
Leukemia. 2010 Jun;24(6):1186-96
pubmed: 20428202
Hematol Oncol. 2020 Oct;38(4):417-424
pubmed: 32469432
Gastroenterology. 1999 Nov;117(5):1105-12
pubmed: 10535873
J Pathol. 2008 Aug;215(4):431-44
pubmed: 18561120
J Clin Invest. 2006 Jan;116(1):22-6
pubmed: 16395399
Ther Adv Med Oncol. 2021 Jul 23;13:17588359211033825
pubmed: 34621332
Leukemia. 2010 Jan;24(1):22-32
pubmed: 19907437
Lancet. 1991 Nov 9;338(8776):1175-6
pubmed: 1682595
Blood. 2007 Apr 15;109(8):3500-4
pubmed: 17197434
Cancer. 1983 Oct 15;52(8):1410-6
pubmed: 6193858
Cancer Res. 2010 Jul 15;70(14):5740-8
pubmed: 20587516
Ann Oncol. 2008 Jul;19(7):1336-1339
pubmed: 18334510
Br J Haematol. 2018 Sep;182(6):913-915
pubmed: 28771670
Lab Invest. 1999 Mar;79(3):261-9
pubmed: 10092062
Oncogene. 2001 Sep 10;20(40):5580-94
pubmed: 11607811
Mod Pathol. 2006 Jan;19(1):141-8
pubmed: 16357845
Int J Cancer. 2004 Aug 10;111(1):1-8
pubmed: 15185336
Hematol Oncol. 2000 Mar;18(1):1-13
pubmed: 10797525
Helicobacter. 2013 Oct;18(5):356-62
pubmed: 23551894
Inflammopharmacology. 2019 Apr;27(2):203-211
pubmed: 30820719
Haematologica. 2011 Jul;96(7):1064-6
pubmed: 21459788
Cancer. 2004 Apr 15;100(8):1578-89
pubmed: 15073843
Semin Immunol. 2006 Oct;18(5):263-75
pubmed: 16914324
Br J Haematol. 2010 Jul;150(2):226-9
pubmed: 20433679
Hematol Oncol. 2010 Mar;28(1):20-6
pubmed: 19728399
Nat Med. 2007 Apr;13(4):470-6
pubmed: 17401375
Nature. 1994 Feb 3;367(6462):425-8
pubmed: 8107800
J Biol Chem. 2001 Jun 1;276(22):19012-9
pubmed: 11262391
J Invest Dermatol. 2009 Feb;129(2):476-9
pubmed: 18704108
Blood. 2011 Jun 23;117(25):6856-65
pubmed: 21543761
Nat Rev Immunol. 2013 Feb;13(2):118-32
pubmed: 23348416
J Pathol. 2006 Jul;209(3):344-51
pubmed: 16583361
Mol Cell. 2000 Oct;6(4):961-7
pubmed: 11090634
Haematologica. 2018 Aug;103(8):1329-1336
pubmed: 29674500
Blood. 1997 Jun 1;89(11):3909-18
pubmed: 9166827
Oncotarget. 2015 Oct 20;6(32):32439-55
pubmed: 26431276
N Engl J Med. 2004 Jan 15;350(3):213-5
pubmed: 14724298
Curr Opin Immunol. 2008 Apr;20(2):241-6
pubmed: 18508251
Nat Rev Clin Oncol. 2019 Jun;16(6):356-371
pubmed: 30705439
Oncotarget. 2017 Jan 31;8(5):8604-8621
pubmed: 28052005
Oncologist. 2016 Jan;21(1):72-5
pubmed: 26621040
Gastroenterology. 1997 Jun;112(6):1871-5
pubmed: 9178679
Oncogene. 2003 Nov 13;22(51):8337-42
pubmed: 14614457
Br J Haematol. 2015 Feb;168(3):317-27
pubmed: 25316606
World J Gastroenterol. 2005 Jan 7;11(1):89-93
pubmed: 15609403
Br J Haematol. 2005 May;129(3):373-6
pubmed: 15842661
Mod Pathol. 2019 Jun;32(6):741-754
pubmed: 30666052
Am J Hematol. 2014 Aug;89(8):E116-20
pubmed: 24723438
Cancers (Basel). 2019 Apr 17;11(4):
pubmed: 30999581
Front Immunol. 2018 Mar 13;9:302
pubmed: 29593707
Ecancermedicalscience. 2015 Feb 24;9:513
pubmed: 25729426
Arch Med Res. 2016 May;47(4):245-54
pubmed: 27664483
J Pathol. 1996 Feb;178(2):122-7
pubmed: 8683376
Immunol Rev. 2009 May;229(1):152-72
pubmed: 19426221
PLoS One. 2012;7(12):e51681
pubmed: 23284739
Ann Oncol. 2020 Jan;31(1):17-29
pubmed: 31912792
J Hematol Oncol. 2009 Aug 12;2:36
pubmed: 19674465
Science. 2008 Mar 21;319(5870):1676-9
pubmed: 18323416
Br J Cancer. 2007 Oct 8;97(7):949-51
pubmed: 17876330
Oncotarget. 2016 Jan 19;7(3):3394-402
pubmed: 26657504
Br J Haematol. 2014 Mar;164(6):804-10
pubmed: 24372375
J Clin Oncol. 2019 May 10;37(14):1188-1199
pubmed: 30897038
Cancers (Basel). 2020 May 28;12(6):
pubmed: 32481736
J Cutan Pathol. 1997 Sep;24(8):457-61
pubmed: 9331890
J Biomed Biotechnol. 2010;2010:104918
pubmed: 20617132
Mol Cell Biol. 2000 Mar;20(5):1877-85
pubmed: 10669762
Cell. 1999 Jan 8;96(1):35-45
pubmed: 9989495
J Natl Cancer Inst. 2004 Apr 21;96(8):586-94
pubmed: 15100336
Oncotarget. 2017 May 23;8(21):34661-34669
pubmed: 28416773
Clin Cancer Res. 2014 Oct 15;20(20):5207-16
pubmed: 25320370
Intern Med. 2018 Mar 15;57(6):789-794
pubmed: 29151525
Nat Rev Cancer. 2004 Aug;4(8):644-53
pubmed: 15286744
Cancer. 2013 Feb 1;119(3):629-38
pubmed: 22893605
Sci Rep. 2020 Sep 9;10(1):14858
pubmed: 32908188
Semin Cancer Biol. 2014 Feb;24:33-42
pubmed: 24333758
Gastroenterol Res Pract. 2015;2015:102656
pubmed: 25922601
Cancer Genet Cytogenet. 1997 Sep;97(2):114-8
pubmed: 9283593
Ann Rheum Dis. 1996 May;55(5):311-6
pubmed: 8660105
Int J Clin Exp Pathol. 2012;5(5):436-41
pubmed: 22808296
Leukemia. 2007 Aug;21(8):1812-8
pubmed: 17554381

Auteurs

Barbara Uhl (B)

Division of Hematology, Medical University of Graz, Graz 8036, Austria.

Katharina T Prochazka (KT)

Division of Hematology, Medical University of Graz, Graz 8036, Austria.

Karoline Fechter (K)

Division of Hematology, Medical University of Graz, Graz 8036, Austria.

Katrin Pansy (K)

Division of Hematology, Medical University of Graz, Graz 8036, Austria.

Hildegard T Greinix (HT)

Division of Hematology, Medical University of Graz, Graz 8036, Austria.

Peter Neumeister (P)

Division of Hematology, Medical University of Graz, Graz 8036, Austria.

Alexander Ja Deutsch (AJ)

Division of Hematology, Medical University of Graz, Graz 8036, Austria. alexander.deutsch@medunigraz.at.

Classifications MeSH